Summary The proepicardial organ is an important transient structure that contributes cells to various cardiac lineages. However, its contribution to the coronary endothelium has been disputed, with conflicting data arising in chick and mouse. Here we resolve this conflict by identifying two proepicardial markers, Scleraxis (Scx) and Semaphorin3D (Sema3D), that genetically delineate heretofore uncharacterized proepicardial subcompartments. In contrast to previously fate mapped Tbx18/WT-1-expressing cells that give rise to vascular smooth muscle, Scx and Sema3D-expressing proepicardial cells give rise to coronary vascular endothelium both in vivo and in vitro. Furthermore, Sema3D+ and Scx+ proepicardial cells contribute to the early sinus venosus and cardiac endocardium, respectively, two tissues linked to vascular endothelial formation at later stages. Taken together, our studies demonstrate that the proepicardial organ is a molecularly compartmentalized structure, reconciling prior chick and mouse data and providing a more complete understanding of the progenitor populations that establish the coronary vascular endothelium.

Background-Microcomputed tomography (micro-CT) has been used extensively in research to generate high-resolution 3D images of calcified tissues in small animals nondestructively. It has been especially useful for the characterization of skeletal mutations but limited in its utility for the analysis of soft tissue such as the cardiovascular system. Visualization of the cardiovascular system has been largely restricted to structures that can be filled with radiopaque intravascular contrast agents in adult animals. Recent ex vivo studies using osmium tetroxide, iodinated contrast agents, inorganic iodine, and phosphotungstic acid have demonstrated the ability to stain soft tissues differentially, allowing for high intertissue contrast in micro-CT images. In the present study, we demonstrate the application of this technology for visualization of cardiovascular structures in developing mouse embryos using Lugol solution (aqueous potassium iodide plus iodine). Methods and Results-We show the optimization of this method to obtain ex vivo micro-CT images of embryonic and neonatal mice with excellent soft-tissue contrast. We demonstrate the utility of this method to visualize key structures during cardiovascular development at various stages of embryogenesis. Our method benefits from the ease of sample preparation, low toxicity, and low cost. Furthermore, we show how multiple cardiac defects can be demonstrated by micro-CT in a single specimen with a known genetic lesion. Indeed, a previously undescribed cardiac venous abnormality is revealed in a PlexinD1 mutant mouse. Conclusions-Micro-CT of iodine-stained tissue is a valuable technique for the characterization of cardiovascular development and defects in mouse models of congenital heart disease. (Circ Cardiovasc Imaging. 2010;3:314-322.)Key Words: micro-CT Ⅲ iodine Ⅲ mouse Ⅲ development Ⅲ PlexinD1 Ⅲ congenital heart disease T he ability to genetically manipulate the mouse has resulted in a powerful model system for the investigation of many disease processes. In particular, genetic studies in the mouse have enhanced our understanding of embryonic development, and by extension, of congenital defects. In humans, cardiac defects are the most common serious anomalies among live births with an estimated frequency of 0.6%. 1 Numerous mouse models of congenital heart disease have been generated and characterized, adding greater insight into the molecular and cellular origins of these defects. 2 In addition, current research in the area of targeted gene deletions holds great promise to further elucidate mechanisms of cardiac development. Editorial see p 228 Clinical Perspective on p 322Although structurally similar to the human, the significantly reduced size of the murine cardiovascular system presents a number of technical challenges when attempting to stage anatomic features such as vascular structures. Identification and characterization of the phenotype of cardiovascular defects in mice traditionally has relied on histological analysis of sectioned specimens. Histology,...

Diethylstilbestrol (DES) was used in the United States from 1947 to 1971 to prevent miscarriage. Approximately one-million women were exposed in utero to DES (ref. 1). Women prenatally exposed to DES commonly display epithelial and/or structural changes in the uterus, cervix, or vagina, and can develop clear cell adenocarcinoma of the vagina or cervix at an early age [2][3][4][5] . The frequency of DES-associated reproductive tract anomalies 6 and cancer 7 appears temporally related to the time of exposure, with most abnormal findings occurring in women exposed to DES in the first trimester. The specific molecular response to DES that fully accounts for the DES syndrome remains unknown. We recently reported that mice lacking Wnt7a have malformed female reproductive tracts 8 (FRTs). The observed phenotype closely resembles the reproductive tract morphologies observed in female mice prenatally exposed to DES (ref. 9), and indicates that Wnt7a may have a role in the DES response in the developing FRT.To directly compare the effects of loss of Wnt7a with the effects of DES in the FRT, we generated mice with DES-induced malformed FRTs using an established protocol 9,10 . DESexposed mice had shallow vaginal fornices, malformed oviducts that lacked coils, Wolffian duct remnants (Fig. 1a), vaginal concretions and adenotic lesions in the vagina 9,11,12 . Wnt7a −/− mice also had shallow vaginal fornices (data not shown) and malformed oviducts 8 . Similarly, Wnt7a −/− FRTs contained Wolffian duct remnants (Fig. 1b), vaginal concretions ( Fig. 1c) and epithelial inclusions in the vaginal stroma (Fig. 1d). Control FRTs (oil treated) had normal morphology and tissue cytoarchitecture (Fig. 1e). DES-exposed and Wnt7a −/− FRTs displayed stratified epithelium with reduced stroma and glands (Fig. 1f,g). DESexposed women were reported to display uterine abnormalities which were attributed to abnormal smooth muscle proliferation 13 . Both Wnt7a −/− and DES-exposed mice had a disorganized and thickened inner layer of smooth muscle (Fig. 1i-k).Wnt7a is normally expressed perinatally in the luminal epithelium of the uterus 8 . As expected, Wnt7a was found to be expressed in the epithelium of the control uterus (Fig.2 b,d). In the DES-exposed uteri, however, low levels of Wnt7a transcripts were detected at birth (Fig. 2f). Wnt7a expression in the DES-exposed uteri returned to high levels five days after birth (Fig. 2h) and was maintained at later stages (data not shown).Correspondence should be addressed to D.A.S. (dsassoo@smtplink.mssm.edu). HHS Public AccessAuthor manuscript Nat Genet. Author manuscript; available in PMC 2016 February 11. Published in final edited form as:Nat Genet. 1998 November ; 20(3): 228-230. doi:10.1038/3027. Author ManuscriptAuthor Manuscript Author Manuscript Author ManuscriptPrevious studies have shown that cytodifferentiation of the female reproductive tract in mice is determined 5-7 days after birth and is dependent on mesenchymal-epithelial interactions 14 . After this time period, the uterine epithelium ...

PlexinD1 is a membrane-bound receptor that mediates signals derived from class 3 secreted semaphorins. Although semaphorin signaling in axon guidance in the nervous system has been extensively studied, functions outside the nervous system including important roles in vascular patterning have also been demonstrated. Inactivation of plexinD1 leads to neo-natal lethality, structural defects of the cardiac outflow tract, peripheral vascular abnormalities, and axial skeletal morphogenesis defects. PlexinD1 is expressed by vascular endothelial cells, but additional domains of expression have also been demonstrated including in lymphocytes, osteoblasts, neural crest and the central nervous system. Hence, the cell-type specific functions of plexinD1 have remained unclear. Here, we describe the results of tissue-specific gene inactivation of plexinD1 in Tie2 expressing precursors, which recapitulates the null phenotype with respect to congenital heart, vascular, and skeletal abnormalities resulting in neonatal lethality. Interestingly, these mutants also have myocardial defects not previously reported. In addition, we demonstrate functions for plexinD1 in post-natal retinal vasculogenesis and adult angiogenesis through the use of inducible cre-mediated deletion. These results demonstrate an important role for PlexinD1 in embryonic and adult vasculature.

Total anomalous pulmonary venous connection (TAPVC) is a potentially lethal congenital disorder that occurs when the pulmonary veins do not connect normally to the left atrium, allowing mixing of pulmonary and systemic blood1. In contrast to the extensive knowledge of arterial vascular patterning, little is known about the patterning of veins. Here we show that the secreted guidance molecule semaphorin 3d (Sema3d) is crucial for the normal patterning of pulmonary veins. Prevailing models suggest that TAPVC occurs when the midpharyngeal endothelial strand (MES), the precursor of the common pulmonary vein, does not form at the proper location on the dorsal surface of the embryonic common atrium2,3. However, we found that TAPVC occurs in Sema3d mutant mice despite normal formation of the MES. In these embryos, the maturing pulmonary venous plexus does not anastomose uniquely with the properly formed MES. In the absence of Sema3d, endothelial tubes form in a region that is normally avascular, resulting in aberrant connections. Normally, Sema3d provides a repulsive cue to endothelial cells in this area, establishing a boundary. Sequencing of SEMA3D in individuals with anomalous pulmonary veins identified a phenylalanine-to-leucine substitution that adversely affects SEMA3D function. These results identify Sema3d as a crucial pulmonary venous patterning cue and provide experimental evidence for an alternate developmental model to explain abnormal pulmonary venous connections.

Objectives Aneurysm of the atrial septum (AAS) with excessive excursion of septum primum into the left atrium is an uncommon and relatively benign fetal condition associated with impediment to left ventricular (LV) filling

Pax3 is a transcription factor expressed in somitic mesoderm, dorsal neural tube and pre-migratory neural crest during embryonic development. We have previously identified cis-acting enhancer elements within the proximal upstream genomic region of Pax3 that are sufficient to direct functional expression of Pax3 in neural crest. These elements direct expression of a reporter gene to pre-migratory neural crest in transgenic mice, and transgenic expression of a Pax3 cDNA using these elements is sufficient to rescue neural crest development in mice otherwise lacking endogenous Pax3. We show here that deletion of these enhancer sequences by homologous recombination is insufficient to abrogate neural crest expression of Pax3 and results in viable mice. We identify a distinct enhancer in the fourth intron that is also capable of mediating neural crest expression in transgenic mice and zebrafish. Our analysis suggests the existence of functionally redundant neural crest enhancer modules for Pax3.

Fibronectin (Fn1) is an evolutionarily conserved extracellular matrix glycoprotein essential for embryonic development. Global deletion of Fn1 leads to mid-gestation lethality from cardiovascular defects. However, severe morphogenetic defects that occur early in embryogenesis in these embryos precluded assigning a direct role for Fn1 in cardiovascular development. We noticed that Fn1 is expressed in strikingly non-uniform patterns during mouse embryogenesis, and that its expression is particularly enriched in the pharyngeal region corresponding with the pharyngeal arches 3, 4, and 6. This region bears a special importance for the developing cardiovascular system, and we hypothesized that the localized enrichment of Fn1 in the pharyngeal region may be essential for cardiovascular morphogenesis. To test this hypothesis, we ablated Fn1 using the Isl1Cre knock-in strain of mice. Deletion of Fn1 using the Isl1Cre strain resulted in defective formation of the 4th pharyngeal arch arteries (PAAs), aberrant development of the cardiac outflow tract (OFT), and ventricular septum defects. To determine the cell types responding to Fn1 signaling during cardiovascular development, we deleted a major Fn1 receptor, integrin α5 using the Isl1Cre strain, and observed the same spectrum of abnormalities seen in the Fn1 conditional mutants. Additional conditional mutagenesis studies designed to ablate integrin α5 in distinct cell types within the Isl1+ tissues and their derivatives, suggested that the expression of integrin α5 in the pharyngeal arch mesoderm, endothelium, surface ectoderm and the neural crest were not required for PAA formation. Our studies suggest that an (as yet unknown) integrin α5-dependent signal extrinsic to the pharyngeal endothelium mediates the formation of the 4th PAAs.